Israel’s NovellusDx monitors the effect of cancer therapies on a patient’s genetic mutations.  NovellusDx reports to the oncologist on the contribution of the driver mutations to the activation of the signaling pathways.  NovellusDx has just received $2.5 million funds from … Continue reading →

Israeli Marni Mandell launched the startup CareHood to provide patients and care-givers with a website where they can learn what has helped other people in similar situations. They can then build a care package of services, gifts, tasks and errands … Continue reading →

Scientists at Bar-Ilan University have used low-level electricity to increase the rate at which daydreams – or spontaneous, self-directed thoughts and associations – occur.  They also discovered that daydreams have a positive effect on task performance. http://www.medicalnewstoday.com/releases/289896.php

A new medical innovation, developed at Tel Aviv University’s Center for Nanoscience & Nanotechnology, uses ‘stick it and forget it’ electrodes affixed to the skin, to monitor muscle activity.  Applications include monitoring driver alertness and individuals with neuro-degenerative diseases. http://unitedwithisrael.org/new-israeli-developed-stickers-can-detect-and-map-emotions/ … Continue reading →

Canada’s federal department responsible for helping Canadians maintain and improve their health, Health Canada, has approved the Exablate Neuro system for the treatment of essential tremor developed by Israel’s Insightec. http://www.insightec.com/news-events/press-releases/2016/health-canada-approves-insightec-s-exablate-neuro-system-for-the-treatment-of-essential-tremor/

The SafeCT-29 solution from Israel’s Medic Vision Imaging Solutions produces high-quality medical scan images but reduces radiation doses by up to 80%.  SafeCT-29 works with any CT scanner and has just been approved by the US FDA. https://www.youtube.com/watch?v=wIxekstfs5k http://www.medicvision.com/en/home

I reported about Israel’s Check-cap previously (Feb 2012) that requires no prior preparation or hospital visit.  After 4 years, trials on 54 participants of its ingestible and disposable low-dose 3D imaging capsule proved safe and well tolerated and detected small … Continue reading →